CD56 [neural cell adhesionmolecule (NCAM)] marker is expressed in 62-82% ofplasma cells in MM patients and is involved in cell attachmentto cellular components of the bone marrowmicroenvironment. Here, NCAM1 is linked to Miyoshi myopathy.